Intellectual Property India Publishes Patent Application for 'Anti-EGFRVIII Antibodies And Uses Thereof' Filed by Phanes Therapeutics, Inc.

MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517048063 A) filed by Phanes Therapeutics, Inc., San Diego, on May 19, for 'anti-egfrviii antibodies and uses thereof.'

Inventor(s) include Wu, Huiwen; Jia, Haiqun; and Zou, Hui.

The application for the patent was published on June 6, under issue no. 23/2025.

According to the abstract released by the Intellectual Property India: "Anti-EGFRvIII antibodies and antigen-binding fragments thereof and chimeric antigen receptors (CARs) comprising anti-EGFRvIII antigen-binding domains are described. Also described are nucleic acids encoding the antibodies and CARs, compositions comprising the antibodies and host cells comprising the CARs, methods of produ...